AI Summary
The world's largest generic drugmaker, Teva, is facing an EU antitrust fine for disparaging a rival multiple sclerosis medicine, according to sources. This action highlights the importance of fair competition and the consequences of negative practices in the pharmaceutical industry.
Teva, the world’s largest generic drugmaker, will be hit with an EU antitrust fine in the coming weeks for disparaging a rival product to its blockbuster multiple sclerosis…
Reuters Health Information